• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Models of hepatic elimination: comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination.

作者信息

Roberts M S, Donaldson J D, Rowland M

机构信息

School of Pharmacy, University of Tasmania, Hobart, Australia.

出版信息

J Pharmacokinet Biopharm. 1988 Feb;16(1):41-83. doi: 10.1007/BF01061862.

DOI:10.1007/BF01061862
PMID:3373419
Abstract

The residence time distribution of noneliminated solutes in the liver can be represented by a variety of stochastic models. The dispersion model (closed and mixed boundary conditions), gamma distribution, log normal distribution and normal distribution models were used to describe output concentration-time profiles after bolus injections into the liver of labeled erythrocytes and albumin. The dispersion model and log normal distribution model provide the best representation of the data and give similar estimates of relative dispersion and availability for varying hepatocellular enzyme activity. The availability of solutes eliminated from the liver by first-order kinetics is determined by the residence time distribution of the solute in the liver and not on events occurring in the liver when a uniform enzyme distribution is assumed. Both enzyme heterogeneity (axial or transverse) and hepatocyte permeability may affect solute availability. A more complex model accounting for enzyme distribution and the micromixing of solute within the liver is required for solutes undergoing saturable kinetics.

摘要

相似文献

1
Models of hepatic elimination: comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination.
J Pharmacokinet Biopharm. 1988 Feb;16(1):41-83. doi: 10.1007/BF01061862.
2
A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.肝脏消除的弥散模型:1. 模型的建立及大剂量注射的考量
J Pharmacokinet Biopharm. 1986 Jun;14(3):227-60. doi: 10.1007/BF01106706.
3
Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model.用扩展对流扩散模型对肝脏消除和器官分布动力学进行建模。
J Pharmacokinet Biopharm. 1999 Aug;27(4):343-82. doi: 10.1023/a:1020992421184.
4
Residence time distribution of diazepam in the isolated perfused rat liver. Analysis with the axial dispersion model.地西泮在离体灌注大鼠肝脏中的停留时间分布。用轴向扩散模型进行分析。
Rev Esp Fisiol. 1992 Dec;48(4):221-9.
5
Availability predictions by hepatic elimination models for Michaelis-Menten kinetics.基于米氏动力学的肝脏消除模型的可用性预测。
J Pharmacokinet Biopharm. 1989 Dec;17(6):687-719. doi: 10.1007/BF01062125.
6
Application of the axial dispersion model of hepatic drug elimination to the kinetics of diazepam in the isolated perfused rat liver.肝药物消除轴向扩散模型在离体灌注大鼠肝脏中地西泮动力学的应用。
J Pharmacokinet Biopharm. 1992 Apr;20(2):171-93. doi: 10.1007/BF01071000.
7
A compartmental model of hepatic disposition kinetics: 1. Model development and application to linear kinetics.
J Pharmacokinet Pharmacodyn. 2002 Apr;29(2):131-56. doi: 10.1023/a:1019703607647.
8
Application of the dispersion model for description of the outflow dilution profiles of noneliminated reference indicators in rat liver perfusion studies.弥散模型在大鼠肝脏灌注研究中用于描述未消除参考指标流出稀释曲线的应用。
J Pharmacokinet Biopharm. 1998 Apr;26(2):163-81. doi: 10.1023/a:1020557706994.
9
Commentary: using the convection-dispersion model and transit time density functions in the analysis of organ distribution kinetics.
J Pharm Sci. 2000 Dec;89(12):1579-86. doi: 10.1002/1520-6017(200012)89:12<1579::aid-jps8>3.0.co;2-y.
10
Interconnected-tubes model of hepatic elimination: steady-state considerations.
J Theor Biol. 1999 Aug 21;199(4):435-47. doi: 10.1006/jtbi.1999.0970.

引用本文的文献

1
A Complete Extension of Classical Hepatic Clearance Models Using Fractional Distribution Parameter f in Physiologically Based Pharmacokinetics.使用生理药代动力学中的分数分布参数 f 对经典肝脏清除模型进行全面扩展。
J Pharm Sci. 2024 Jan;113(1):95-117. doi: 10.1016/j.xphs.2023.05.019. Epub 2023 Jun 4.
2
A gamma-distribution convolution model of Tc-MIBI thyroid time-activity curves.Tc-MIBI 甲状腺时间-活性曲线的伽马分布卷积模型。
EJNMMI Phys. 2016 Dec;3(1):31. doi: 10.1186/s40658-016-0166-z. Epub 2016 Dec 16.
3
Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

本文引用的文献

1
THEORY OF THE USE OF ARTERIOVENOUS CONCENTRATION DIFFERENCES FOR MEASURING METABOLISM IN STEADY AND NON-STEADY STATES.利用动静脉浓度差测量稳态和非稳态代谢的理论
J Clin Invest. 1961 Dec;40(12):2111-25. doi: 10.1172/JCI104437.
2
Flow dependence of first-order uptake of substances by heterogeneous perfused organs.
J Theor Biol. 1980 Sep 21;86(2):365-76. doi: 10.1016/0022-5193(80)90012-0.
3
Moments of physiological transit time distributions and the time course of drug disposition in the body.生理转运时间分布的时刻以及药物在体内处置的时间进程。
理解药代动力学/药效动力学关系中的滞后环难题。
J Pharm Pharm Sci. 2014;17(1):34-91.
4
Reassessing models of hepatic extraction.重新评估肝脏摄取模型。
J Biol Phys. 2003 Mar;29(1):1-21. doi: 10.1023/A:1022531403741.
5
Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.肝细胞坏死、纤维化和微粒体活性决定了右心衰竭性肝损伤患者体内碱性药物的肝药代动力学。
Pharm Res. 2012 Jun;29(6):1658-69. doi: 10.1007/s11095-012-0690-z.
6
Drug structure-transport relationships.药物结构-转运关系。
J Pharmacokinet Pharmacodyn. 2010 Dec;37(6):541-73. doi: 10.1007/s10928-010-9174-0. Epub 2010 Nov 24.
7
Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.利福平在肺结核患者中的群体药代动力学,包括一个描述可变吸收的半机制模型。
Antimicrob Agents Chemother. 2008 Jun;52(6):2138-48. doi: 10.1128/AAC.00461-07. Epub 2008 Apr 7.
8
Effects of old age on vascular complexity and dispersion of the hepatic sinusoidal network.衰老对肝窦网络血管复杂性和分散性的影响。
Microcirculation. 2008 Apr;15(3):191-202. doi: 10.1080/10739680701600856.
9
Human physiologically based pharmacokinetic model for propofol.丙泊酚的人体生理药代动力学模型。
BMC Anesthesiol. 2005 Apr 22;5(1):4. doi: 10.1186/1471-2253-5-4.
10
Hepatic pharmacokinetics of taurocholate in the normal and cholestatic rat liver.牛磺胆酸盐在正常和胆汁淤积大鼠肝脏中的肝药代动力学。
Br J Pharmacol. 2005 May;145(1):57-65. doi: 10.1038/sj.bjp.0706148.
J Math Biol. 1982;15(3):305-18. doi: 10.1007/BF00275690.
4
Hepatic transport kinetics: effect of anatomic and metabolic heterogeneity on estimates of the average transfer coefficients.肝脏转运动力学:解剖学和代谢异质性对平均转运系数估计值的影响。
Am J Physiol. 1982 Dec;243(6):G532-40. doi: 10.1152/ajpgi.1982.243.6.G532.
5
Functional implications of liver cell heterogeneity.肝细胞异质性的功能意义。
Gastroenterology. 1981 Feb;80(2):393-403.
6
Saturation kinetics in hepatic drug removal: a statistical approach to functional heterogeneity.肝脏药物清除中的饱和动力学:一种针对功能异质性的统计学方法。
Am J Physiol. 1983 Jun;244(6):G583-9. doi: 10.1152/ajpgi.1983.244.6.G583.
7
Flow dependence of propranolol elimination in perfused rat liver.
J Pharmacol Exp Ther. 1984 Aug;230(2):474-7.
8
Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding.通过普萘洛尔蛋白结合的扰动来区分离体灌注大鼠肝脏中肝药物消除的静脉平衡模型和窦状隙模型。
J Pharmacol Exp Ther. 1984 May;229(2):522-6.
9
An understanding of the role of enzyme localization of the liver on metabolite kinetics: a computer simulation.
J Pharmacokinet Biopharm. 1983 Oct;11(5):451-68. doi: 10.1007/BF01062205.
10
Use of gamma distributed residence times in pharmacokinetics.伽马分布的驻留时间在药代动力学中的应用。
Eur J Clin Pharmacol. 1983;25(5):695-702. doi: 10.1007/BF00542361.